Public Act No. 21-192 Summary

• Adds new definitions to pharmacy statutes including "deprescribing," "medication reconciliation," and "polypharmacy" to expand pharmacist clinical capabilities and drug therapy management.

• Authorizes long-term care pharmacies to operate automated prescription dispensing machines in nursing homes with Department of Consumer Protection approval at $100 annual fee per machine.

• Expands collaborative drug therapy management agreements to allow pharmacists to implement, modify, continue, discontinue, or deprescribe drugs with physician or advanced practice nurse approval, with 24-hour notification requirement for discontinuance.

• Establishes syringe services program vending machines accessible through secure technology, allowing distribution of up to 10 needles/syringes per transaction to authorized program participants.

• Adds diabetes medication and device reporting requirements to the prescription drug monitoring program, requiring daily reporting of insulin drugs, glucagon drugs, diabetes devices, and diabetic ketoacidosis devices.